Roche Wins U.S. Nod to Sell Hemlibra to Most Hemophilia Patients

(Bloomberg) -- Roche Holding AG won U.S. regulatory approval to sell its Hemlibra medicine to the largest group of hemophilia patients, bolstering the Swiss drugmaker’s effort to branch away from c...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.